A state lawmaker has introduced a bill proposing state oversight, in additional to existing federal oversight, of ONRPC. Peter Barr-Gillespie, Ph.D., said: “We seek to foster a culture of excellence across all missions, and in doing so, provide the information necessary to reinforce and strengthen our commitment to quality, safety and service to all Oregonians. We also strive to provide a workplace and learning environment that is safe and welcoming for all. As Oregon’s academic health center, we are continually learning and working to identify opportunities for improvement.”

A state lawmaker has introduced a bill proposing state oversight, in additional to existing federal oversight, of ONRPC. Peter Barr-Gillespie, Ph.D., said: “We seek to foster a culture of excellence across all missions, and in doing so, provide the information necessary to reinforce and strengthen our commitment to quality, safety and service to all Oregonians. We also strive to provide a workplace and learning environment that is safe and welcoming for all. As Oregon’s academic health center, we are continually learning and working to identify opportunities for improvement.”

An article from Health Day highlights the findings of an OHSU-led study, which found that emergency departments with high pediatric readiness have lower short-term and long-term mortality among children.

Sarunas Sliesoraitis, M.D., joins the Columbia Memorial Hospital - OHSU Knight Cancer Collaborative as a new medical oncologist.

Peter G. Jacobs, Ph.D., and Leah M. Wilson, M.D., are organizing a clinical trial to evaluate how well patients can better manage their type 1 diabetes with the help of their artificial intelligence-powered app and the support of human experts in diabetes and behavioral health.

OHSU and Oregon State University researchers are developing a new approach to gene therapy for inherited forms of blindness that uses lipid nanoparticles to deliver gene-altering mRNA.

EverOut/Portland reports that Larry Sherman, Ph.D., will join the Portland Chamber Orchestra and singer Naomi LaViolette, mixing music, humor and neuroscience for an event in Beaverton on Valentine’s Day.

In a Pharmacy Times article on at-home, non-invasive tests for colorectal cancer, David Lieberman, M.D., says “I'm hoping to have a new and highly reliable test available for patients soon. One that will allow them to conveniently screen for CRC (colorectal cancer) in their own homes."

An article from The Lund Report reports on Oregon’s newly finalized regulations for the controlled use of the mushroom psilocybin. Atheir Abbas M.D., Ph.D., discusses the medical concerns and gaps in research related to microdosing psilocybin: “Part of the issue is we don't really know…I would predict that psilocybin will be associated with heart disease in people that use it too much. But we don't know; no one has looked.”

Researchers at OHSU are contributing to an international clinical trial exploring possible treatments for Alzheimer’s, specifically focusing on earlier intervention. The AHEAD Study looks at the treatment of a drug called Lecanemab, which could delay memory decline before symptoms of the disease appear.